712 related articles for article (PubMed ID: 16815652)
21. Influence of fumed silicon dioxide on the stabilization of Eudragit RS/RL 30 D film-coated theophylline pellets.
Kucera SA; Stimpel D; Shah NH; Malick AW; Infeld MH; McGinity JW
Pharm Dev Technol; 2008; 13(3):245-53. PubMed ID: 18484493
[TBL] [Abstract][Full Text] [Related]
22. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the film formation of the dry coating process.
Kablitz CD; Urbanetz NA
Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
[TBL] [Abstract][Full Text] [Related]
24. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
[TBL] [Abstract][Full Text] [Related]
25. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
Zhu Y; Mehta KA; McGinity JW
Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
[TBL] [Abstract][Full Text] [Related]
26. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
Li XN; Guo HX; Heinamaki J
J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
[TBL] [Abstract][Full Text] [Related]
27. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
Leopold CS; Eikeler D
J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
[TBL] [Abstract][Full Text] [Related]
28. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
Dave VS; Fahmy RM; Bensley D; Hoag SW
Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
[TBL] [Abstract][Full Text] [Related]
29. Influence of hydroxyethylcellulose on the drug release properties of theophylline pellets coated with Eudragit RS 30 D.
Zheng W; Sauer D; McGinity JW
Eur J Pharm Biopharm; 2005 Jan; 59(1):147-54. PubMed ID: 15567312
[TBL] [Abstract][Full Text] [Related]
30. [Studies on heart-protecting musk pH-dependent gradient-release pellets].
Song HT; Guo T; Zhang RH; Ma Y; Li X; Bi KS
Yao Xue Xue Bao; 2002 Oct; 37(10):812-7. PubMed ID: 12567868
[TBL] [Abstract][Full Text] [Related]
31. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
Kibria G; Islam KM; Jalil RU
Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
[TBL] [Abstract][Full Text] [Related]
32. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
Liu F; Moreno P; Basit AW
Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
[TBL] [Abstract][Full Text] [Related]
33. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
[TBL] [Abstract][Full Text] [Related]
34. Control and stability of drug release from diffusion pellets coated with the aqueous quaternary polymethacrylate dispersion Eudragit RS 30 D.
Lippold BC; Monells Pagés R
Pharmazie; 2001 Jun; 56(6):477-83. PubMed ID: 11446169
[TBL] [Abstract][Full Text] [Related]
35. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions.
Nisar-ur-Rahman ; K H Y; Jia Woei W; Khan NA
Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393
[TBL] [Abstract][Full Text] [Related]
36. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets.
Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW
AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939
[TBL] [Abstract][Full Text] [Related]
37. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
[TBL] [Abstract][Full Text] [Related]
38. Microencapsulated Eudragit RS30D-coated controlled-release pellets: the influence of dissolution variables and topographical evaluation.
Govender T; Dangor CM; Chetty DJ
J Microencapsul; 1997; 14(1):1-13. PubMed ID: 8994071
[TBL] [Abstract][Full Text] [Related]
39. In vitro characterization of a controlled-release chlorpheniramine maleate delivery system prepared by the air-suspension technique.
Mathir ZM; Dangor CM; Govender T; Chetty DJ
J Microencapsul; 1997; 14(6):743-51. PubMed ID: 9394255
[TBL] [Abstract][Full Text] [Related]
40. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
Cerea M; Zheng W; Young CR; McGinity JW
Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
